CAS: 1492952-76-7 - 3-Pyridinecarboxamide, N-[4-(chlorodifluoromethoxy)phenyl]-6-[(3R)-3-hydroxy-1-pyrrolidinyl]-5-(1H-pyrazol-3-yl)-
![3-Pyridinecarboxamide, N-[4-(chlorodifluoromethoxy)phenyl]-6-[(3R)-3-hydroxy-1-pyrrolidinyl]-5-(1H-pyrazol-3-yl)-](https://static.cymitquimica.com/products/AN/thumb/AG001LJ6.jpg)
3-Pyridinecarboxamide, N-[4-(chlorodifluoromethoxy)phenyl]-6-[(3R)-3-hydroxy-1-pyrrolidinyl]-5-(1H-pyrazol-3-yl)-
CAS:1492952-76-7
Formula:
C20H18ClF2N5O3
Purity:
98%
Color and Shape:
Solid
Molecular weight:
449.8384
Ref: AN-AG001LJ6
| 1g | 1,050.00 € | |
| 50mg | 147.00 € | |
| 100mg | 246.00 € | |
| 250mg | 553.00 € |
Estimated delivery in United States, on Monday 6 May 2024
Asciminib
CAS:1492952-76-7
Asciminib (ABL001) (ABL001) is a potent and selective Bcr-Abl inhibitor (Kd: 0.5-0.8nM).
Formula:
C20H18ClF2N5O3
Purity:
99.45%
Color and Shape:
Solid
Molecular weight:
449.84
Ref: TM-T5177
| 1mg | 62.00 € | |
| 2mg | 90.00 € | |
| 5mg | 124.00 € | |
| 10mg | 183.00 € | |
| 25mg | 300.00 € | |
| 50mg | 418.00 € | |
| 100mg | 618.00 € | |
| 500mg | 1,291.00 € | |
| 1ml*10 (DMSO) | 137.00 € |
Estimated delivery in United States, on Monday 13 May 2024
Ref: 4Z-A-330001
| 10mg | To inquire | |
| 25mg | To inquire | |
| 50mg | To inquire | |
| 100mg | To inquire |
Estimated delivery in United States, on Monday 13 May 2024
Ref: TR-C414890
| 250mg | 5,331.00 € |
Estimated delivery in United States, on Tuesday 18 Jun 2024
Asciminib
CAS:1492952-76-7
BCR-ABL tyrosine kinase inhibitor; antineoplastic
Formula:
C20H18ClF2N5O3
Purity:
Min. 95%
Molecular weight:
449.84 g/mol
Ref: 3D-BA166957
| 1mg | To inquire | |
| 5mg | To inquire | |
| 10mg | To inquire |
Estimated delivery in United States, on Monday 17 Jun 2024
